gene therapy

R.A. Session II, president, CEO, and founder of Taysha Gene Therapies [Background image: Olena Yepifanova via iStock]

Dallas Gene Therapy Startup Closes $95M Series B to Bolster its Initial Clinical Studies

Taysha Gene Therapies, which was been operating in stealth with UT Southwestern until this April, plans to use the financing to advance its initial cohort of lead programs into its clinic. By the end of 2021, Taysha expects to file four Investigational New Drug applications.
MORE
research birds
Discovery: SMU and UTSW Figure Out How Birds Migrate at Night, Scientists Find Possible Polycystic Kidney Disease Drug
by | Sep 13, 2019
In this weekly roundup of research and development activity in North Texas, you’ll also read about how an SMU professor and students from Garland High School are using smartphone data to monitor a local bridge’s health.
MORE
McKesson and TrakCel Form a Collaboration to Commercialize Cell and Gene Therapies
by | Sep 12, 2019
Together, the two companies aim to increase access to complex medications and ensure that patients more quickly receive the correct drug at the right time.
MORE
Biologics Company LakePharma Opens Dallas Office
by | Jul 30, 2019
Providing integrated solutions ranging from discovery to engineering, biologics CRDMO LakePharma made its Dallas debut earlier this summer.
MORE